TABLE OF CONTENTS
1 REPORT PROLOGUE
2 MARKET INTRODUCTION
2.1 INTRODUCTION
2.2 SCOPE OF STUDY
2.3 RESEARCH OBJECTIVE
2.4 ASSUMPTIONS & LIMITATIONS
2.4.1 ASSUMPTIONS
2.4.2 LIMITATIONS
3 RESEARCH METHODOLOGY
3.1 RESEARCH PROCESS
3.2 PRIMARY RESEARCH
3.3 SECONDARY RESEARCH
4 MARKET DYNAMICS
4.1 DRIVERS
4.2 RESTRAINS
4.3 OPPORTUNITIES
4.4 CHALLENGES
5 MARKET FACTOR ANALYSIS
5.1 PORTER’S FIVE FORCES MODEL
5.1.1 BARGAINING POWER OF SUPPLIERS
5.1.2 BARGAINING POWER OF BUYERS
5.1.3 THREAT OF NEW ENTRANTS
5.1.4 THREAT OF SUBSTITUTES
5.1.5 INTENSITY OF RIVALRY
5.2 SUPPLY CHAIN ANALYSIS
6 GLOBAL SURGICAL CHIPS MARKET, BY TYPES
6.1 DNA CHIPS
6.2 BRAIN CHIPS
6.3 LAB CHIPS
6.4 PROTEIN CHIPS
6.5 TISSUE CHIP
7 GLOBAL SURGICAL CHIPS MARKET, BY APPLICATION
7.1 CANCER DIAGNOSIS AND TREATMENT
7.2 GENE EXPRESSION
7.3 SNP GENOTYPING
7.4 GENOMICS
7.5 CLINICAL DIAGNOSTICS
7.6 OTHERS
8 GLOBAL SURGICAL CHIPS MARKET, BY END USER
8.1 HOSPITALS
8.2 RESEARCH CENTERS
8.3 OTHERS
9 GLOBAL SURGICAL CHIPS MARKET, BY REGION
9.1 INTRODUCTION
9.2 MARKET SIZE BY REGION
9.2.1 AMERICAS
9.2.1.1 NORTH AMERICA
9.2.1.1.1 US
9.2.1.1.2 CANADA
9.2.1.2 SOUTH AMERICA
9.2.2 EUROPE
9.2.2.1 WESTERN EUROPE
9.3.2.1.1 GERMANY
9.3.2.1.2 FRANCE
9.3.2.1.3 ITALY
9.3.2.1.4 SPAIN
9.3.2.1.5 UK
9.2.2.2 EASTERN EUROPE
9.2.3 ASIA-PACIFIC
9.2.3.1 ASIA
9.2.3.1.1 CHINA
9.2.3.1.2 INDIA
9.2.3.1.3 JAPAN
9.2.3.1.4 RUPUBLIC OF SOUTH KOREA
9.2.3.2 PACIFIC
9.4 MIDDLE EAST & AFRICA
9.4.1 MIDDLE EAST
9.4.1.1 UAE
9.4.1.2 SAUDI ARABIA
9.4.2 AFRICA
.4.2.1 EGYPT
9.4.3 REST OF MIDDLE EAST AND AFRICA
10 COMPANY PROFILE
10.1 Allied Healthcare Products
10.1.1 OVERVIEW
10.1.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
10.1.3 FINANCIAL UPDATES
10.1.4 KEY DEVELOPMENTS
10.2 Becton, Dickinson and Company
10.2.1 OVERVIEW
10.2.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
10.2.3 FINANCIAL UPDATES
10.2.4 KEY DEVELOPMENTS
10.3 Drägerwerk AG & Co. KGaA
10.3.1 OVERVIEW
10.3.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
10.3.3 FINANCIAL UPDATES
10.3.4 KEY DEVELOPMENTS
10.4 GE Healthcare
10.4.1 OVERVIEW
10.4.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
10.4.3 FINANCIAL UPDATES
10.4.4 KEY DEVELOPMENTS
10.5 Getinge Group
10.5.1 OVERVIEW
10.5.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
10.5.3 FINANCIAL UPDATES
10.5.4 KEY DEVELOPMENTS
10.6 Hamilton Medical AG
10.6.1 OVERVIEW
10.6.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
10.6.3 FINANCIAL UPDATES
10.6.4 KEY DEVELOPMENTS
10.7 Medtronic
10.7.1 COMPANY OVERVIEW
10.7.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
10.7.3 FINANCIAL UPDATES
10.7.4 KEY DEVELOPMENT
10.8 Philips Healthcare
10.8.1 OVERVIEW
10.8.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
10.8.3 FINANCIAL OVERVIEW
10.8.4 KEY DEVELOPMENT
10.9 ResMed
10.9.1 COMPANY OVERVIEW
10.9.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
10.9.3 FINANCIAL UPDATES
10.9.4 KEY DEVELOPMENT
10.10 Smiths Group plc
10.10.1 OVERVIEW
10.10.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
10.10.3 FINANCIAL OVERVIEW
10.10.4 KEY DEVELOPMENT
10.11 Teleflex Incorporated
10.11.1 COMPANY OVERVIEW
10.11.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
10.11.3 FINANCIAL UPDATES
10.11.4 KEY DEVELOPMENT
10.12 OTHERS
11. CONCLUSION
11.1 KEY Findings
11.1.1 FROM CEO’S VIEWPOINT
11.1.2 UNMET NEEDS OF THE MARKET
11.2 KEY COMPANIES TO WATCH
11.3 PREDICTION OF SURGICAL CHIPS MARKET
12. APPENDIX